- January 20, 2026
- 0 Comment
Nature Medicine, Published online: 20 January 2026; doi:10.1038/s41591-025-04151-2
MedHELM, an extensible evaluation framework including a new taxonomy for classifying medical tasks and a benchmark of many datasets across these categories, enables the evaluation of large language models on real-world clinical tasks.- January 20, 2026
- 0 Comment
Nature Medicine, Published online: 19 January 2026; doi:10.1038/s41591-025-04176-7
In a trial involving 2,069 patients and 111 clinicians across 24 disciplines, patients performing a preconsultation session with an LLM-powered chatbot had a significantly lower consultation time and both patients and clinicians reported improved communication and satisfaction.- January 19, 2026
- 0 Comment
Nature Medicine, Published online: 19 January 2026; doi:10.1038/s41591-025-04140-5
Upregulation of the ventral tegmental area via neurofeedback is associated with a stronger immune response to hepatitis B virus vaccination, and VTA upregulation is achieved through conscious positive expectations.- January 19, 2026
- 0 Comment
Nature Medicine, Published online: 19 January 2026; doi:10.1038/s41591-025-04168-7
A randomized trial provides direct human evidence that the placebo effect can shape humoral immunity, showing that reward-related brain activity correlates with vaccine-induced antibody production and opening new avenues for treating many medical conditions.- January 19, 2026
- 0 Comment
Nearly 1,000 food industry professionals will gather in Kalamazoo, Mich., March 24–25, 2026 for the WMU Food Marketing Conference. The event blends executive insight, emerging talent and timely topics—from AI to health and wellness—shaping food and CPG marketing.
- January 16, 2026
- 0 Comment
EcoVadis, a leading global provider of business sustainability ratings, has awarded the EXBERRY color supplier a Platinum medal. The achievement marks another important step forward for the company following Silver and Gold medals in the previous two assessment periods.
- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04141-4
In an arm of an ongoing multicenter phase 2 trial testing different therapies in patients with genetically profiled grade 2 or 3 meningiomas, treatment with an oral CDK4/6 inhibitor met the primary endpoint for progression-free survival at 6 months in patients with CDK or NF2 alterations.- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04163-y
Lessons from Rwanda’s response to the Marburg virus outbreak- January 16, 2026
- 0 Comment
Nature Medicine, Published online: 16 January 2026; doi:10.1038/s41591-025-04160-1
Preparing for tomorrow’s threats by enhancing our ability to help patients today.- January 16, 2026
- 0 Comment
